Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective...
CuePath Innovation, a provider of medication adherence solutions for the home healthcare market, announced that its Director of Medication Adherence, Dr. Margaret Lu, will...
Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced the presentation of preclinical data on the...
GenScript USA Inc., the world's leading life science research tools and services provider, announced the debut of the highest throughput semiconductor chip for DNA...
InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
